Sociedad Americana de Hirudoterapia

Agarose-gel electrophoresis for the quality assurance and purity of heparin formulations

Research article published in Journal of pharmaceutical and biomedical analysis (2012)

Última actualización: June 18, 2026Revisado por: ASH Editorial Board
Research article — evidence reviewArticle reference
Evidence: Research reportDesarrollo de fármacosVolpi N et al. · Journal of pharmaceutical and biomedical analysis, 2012

Abstract

The adulteration of raw heparin (Hep) with a synthetic oversulfated chondroitin sulfate (OSCS) not found in nature produced in 2007-2008 a global crisis giving rise to the development of additional, new and specific methods for its quality assurance and purity. In this study, a simple and sensitive agarose-gel electrophoresis method has been developed for the visualization of OSCS in Hep samples along with other natural glycosaminoglycans possibly present as "process-related impurities", in particular dermatan sulfate (DS) and chondroitin sulfate (CS). Agarose-gel electrophoresis under non-conventional conditions is able to separate OSCS from Hep with its two components, the slow-moving and fast-moving species, DS and CS by performing separation for 15 h (overnight) and under high voltage (100 mA, ∼200 V). Densitometric scanning enabled us to calculate a limit of detection of ∼0.5 μg OSCS with a linear behaviour from 0.1 to 5 μg, comparable to CS/DS. Contaminated samples from Hep manufacturers were analyzed and quantitative data were found comparable to previous studies. Due to its capacity to process many samples in a single run and to the equipment commonly available in laboratories, this analytical method would be suitable for the identification and quantification of contamination by other polysaccharides, in particular OSCS and DS, within Hep preparations and formulations.

Abstract sourced from PubMed (NCBI) for the cited record. See the original publication for the authoritative version.

Publication typeJournal Article
Indexed MeSH termsChemistry, PharmaceuticalElectrophoresis, Agar GelHeparinQuality Control

Resumen

The adulteration of raw heparin (Hep) with a synthetic oversulfated chondroitin sulfate (OSCS) not found in nature produced in 2007-2008 a global crisis giving rise to the development of additional, new and specific methods for its quality assurance and purity.

Por qué esto importa para la hirudoterapia

This study developed an agarose-gel electrophoresis method to detect oversulfated chondroitin sulfate (OSCS) and other natural glycosaminoglycans such as dermatan sulfate and chondroitin sulfate as impurities within heparin formulations following the 2007-2008 heparin crisis. The technique provides a sensitive, accessible way to identify and quantify polysaccharide contamination in heparin preparations and formulations. The abstract does not mention leeches, hirudotherapy, hirudin, or any leech-derived products, and makes no comparison between heparin and leech-based anticoagulants. Consequently, there is no direct relevance to the ASH domain; the work is strictly focused on pharmaceutical quality control of heparin.

Citación

Agarose-gel electrophoresis for the quality assurance and purity of heparin formulations

Volpi N et al. · Journal of pharmaceutical and biomedical analysis, 2012

Contexto clínico relacionado

Explore cómo esta investigación se conecta con la práctica clínica

Añadido a la biblioteca ASH: May 27, 2026 · Última actualización del sitio: June 18, 2026

Este sitio web proporciona información educativa y no constituye consejo médico, diagnóstico ni recomendaciones de tratamiento. La terapia con sanguijuelas medicinales conlleva riesgos clínicamente significativos y debe ser realizada únicamente por profesionales calificados bajo protocolos aprobados institucionalmente. La autorización 510(k) de la FDA para sanguijuelas medicinales se limita a indicaciones específicas; las discusiones sobre uso investigativo y fuera de indicación se señalan correspondientemente. Para orientación médica específica, consulte a un profesional de salud calificado.